1. Introduction {#sec1}
===============

Epidemiological and experimental evidence suggest that physical activity \[[@bib1]\], and consumption of dairy products \[[@bib2],[@bib3]\] associate with decreased risk for metabolic disorders (MD). Metabolic disorder is a constellation of risk factors that commonly occur together, including high blood glucose, triglycerides and blood pressure, and low high-density lipoproteins (HDL). Low-density lipoproteins (LDL) have been associated with traits of metabolic disorder independent of obesity \[[@bib4]\]. The effects of dairy products for improved metabolic health seem to be mediated by the protein components and/or minerals of milk \[[@bib5]\]. Specifically, casein and whey are accounted to produce these beneficial effects \[[@bib5]\]. Compared to casein, whey is especially rich in branched chain amino acids (BCAAs) and thus, the difference in their metabolic effects may arise from the difference in their essential amino acid compositions \[[@bib6]\]. Casein and whey also differ in their postprandial kinetics and satiating effect, exemplified by slower stomach emptying of casein than whey \[[@bib7],[@bib8]\]*.*

BCAAs are essential amino acids used for energy production especially in the skeletal muscle, but also in other tissues, such as brain and adipose tissue. In contrast to other amino acids, BCAAs do not need the first-pass hepatic catabolism for their degradation. BCAAs have numerous physiological functions, one of those being a regulatory role for protein synthesis in skeletal muscle \[[@bib9]\]. Although the beneficial effects of BCAAs on metabolic health \[[@bib9],[@bib10]\] have been linked with the activity of Sirtuin 1 \[[@bib11],[@bib12]\], the detailed mechanistic pathways are not thoroughly known. The possible links to all seven Sirtuins with exercise and BCAA-supplementation have not been previously studied.

Sirtuins are energy level (NAD^+^) -regulated enzymes. They can function as e.g. deacetylases, desuccinylases, demalonylases or ADP-ribosylases, to modify post-translationally a large set of proteins from histones to enzymes of energy metabolism \[[@bib13],[@bib14]\]. Of the sirtuins, Sirt1 has various nuclear and cytosolic targets controlling for instance cell cycle and energy homeostasis \[[@bib13]\] and is considered as one of the key regulators of mitochondrial biogenesis \[[@bib12]\]. Sirt2 regulates gluconeogenesis \[[@bib15]\], and is highly expressed in adipocytes playing a role in metabolic functions \[[@bib16]\]. In skeletal muscle, Sirt3 regulates mitochondrial substrate selection and metabolic flexibility \[[@bib13]\]. Sirt3 level increases e.g. due to caloric restriction or exercise \[[@bib17],[@bib18]\] and can be downregulated in MD \[[@bib19]\]. The main enzymatic activity of Sirt4 is to control BCAA catabolism: without Sirt4 BCAA metabolism is reduced in hepatic and cardiac mitochondria \[[@bib20]\]. Sirt5 desuccinylates, demalonylates and deglutarylates a major portion of proteins related to mitochondrial energy metabolism from Pyruvate Dehydrogenase (PDH) complex, β-oxidation, BCAA catabolism, and Krebs cycle to electron transport chain and ATP synthesis, thus being an important regulator of energy metabolism \[[@bib21]\]. Sirt6 is a multifunctional protein \[[@bib14],[@bib22]\], and acts as one of the key regulators of glucose homeostasis \[[@bib23]\], which is disturbed in MD. Sirt7, in addition to its regulatory tasks e.g. in ribosome biogenesis, genome stability, transcription and RNA metabolism, is a regulator of mitochondrial homeostasis and hepatic lipid metabolism \[[@bib24]\]. An overview of the roles of Sirtuins in metabolic pathways is shown in [Figure S1](#dfig1){ref-type="graphic"}. Because the protein levels of sirtuins adapt to acute or long-term stimuli like exercise or caloric restriction \[[@bib14]\], and skeletal muscles account ∼40% of the body mass and almost 30% of the resting energy consumption in normal human \[[@bib25]\], we sought to study the interplay between skeletal muscle metabolism, Sirtuins and BCAAs.

We previously showed that low capacity runner (LCR) rats score high for developing MD \[[@bib26]\], have greater adiposity \[[@bib27]\] and develop hepatic steatosis even without a high fat challenge \[[@bib28]\], have reduced lifespan \[[@bib29]\], and express less BCAA degradation and fatty acid metabolism-related genes than the high running capacity (HCR) rats \[[@bib30]\]. Thus, it was of special interest to use LCRs to study the separate and combined effects of long-term BCAA supplementation, and exercise on the variables of metabolic health. We hypothesized that either exercise and/or BCAA-rich milk protein supplements would ameliorate the MD risk factors or concurrent regulatory changes would be seen in skeletal muscle Sirtuin levels. HCR/LCR rat model is a polygenic model \[[@bib26]\], and thus, the data derived from them are likely more relevant for translational to humans than that of the commonly used inbred laboratory rodents.

2. Materials and methods {#sec2}
========================

2.1. Animals and intervention measurements {#sec2.1}
------------------------------------------

LCR and HCR rats are produced by two-way artificial selective breeding \[[@bib26],[@bib31]\]. Shortly, breeding started with a large founder population of genetically heterogeneous, outbred rats (N:NIH stock). After testing the running capacity (*i.e.* phenotyping) at 11 weeks of age, the individuals with the lowest and highest running distance were mated to produce the two segregating lines for intrinsic aerobic capacity \[[@bib31]\]. For this study full-grown, phenotyped, female LCR rats from generation 28 of selection were transported from the University of Michigan, USA to Finland at the age of ∼5 months. Animals were single-housed in standard conditions (temperature 21 ± 2°C, humidity 55 ± 10%, light period from 8.00 to 20.00). The experiment was approved by the Regional State Administrative Agency, Southern Finland, Finland (ESAVI-2010-07989/Ym-23), and the Institutional Animal Care & Use Committee (IACUC) at the University of Michigan. Experiment was conducted in accordance with the Guidelines of the European Community Council directives 86/609/EEC, and European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Council of Europe No 123, Strasbourg 1985). The study is reported according to ARRIVE guidelines.

Before the running and diet interventions, we conducted a maximal treadmill running capacity test, and measured body composition, spontaneous activity, and glucose tolerance and insulin sensitivity (see [Fig. 1](#fig1){ref-type="fig"} for study setup). Then, the rats (n = 47, aged 8.7 ± 0.6 months) were divided into six age- and weight-matched groups. Three groups were sedentary and three respective groups were provided running wheels (RW) in their home cages ([Fig. 1](#fig1){ref-type="fig"}). During diet intervention, protein supplements were given in drinking water. Sedentary control or running control animals had free access to tap water, whey (W) groups received whey protein (5.28 ± 0.04 g/kg, Valio) and the protein drink (PD) groups received milk protein drink (5.13 ± 0.02 g/kg, Valio) for 21.4 weeks (150 ± 3 days; ∼5months). All rats had aspen-chips (Tapvei, Kaavi, Finland) as a bedding and nesting material. Sedentary animals were housed in Macrolon IV cages (Techniplast 1354G, Buguggiate, Italy). For the exercise animals, running wheels were mounted onto the housing cages (Techniplast 2154F0105, Buguggiate, Italy), and the wheel (Ø 345 mm) revolutions were recorded 24/7 with a self-constructed computerized system \[[@bib32]\]. All rats were given pelleted rodent diet (R36, Labfor/Lantmännen, Malmö, Sweden) *ad libitum.* Both diet drinks were given each day (seven days a week) as fresh and were available *ad libitum*. Food intake and weight gain were measured at least twice a week. Details of diets are given in the [Supplement 1](#appsec2){ref-type="sec"}, as are the methods for the functional measurements that were done pre- and post-intervention ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Schematic drawing of the study setup showing the groups and the timeline for the measurements.Fig. 1

2.2. Necropsy {#sec2.2}
-------------

Animals were euthanized in random order at metestrous/diestrous -phase. The estrous stage was determined by vaginal smear, stained fresh with Giemsa on objective glass \[[@bib33]\]. Running wheels were blocked 24 h before necropsy to avoid acute effects of running. The rats were fasted overnight, weighed, quickly anesthetized with mixture of air and CO~2~, and then euthanized by cardiac puncture to collect serum samples. Tissue samples were weighted, immediately snap frozen in liquid nitrogen and stored at −80°C. For the weight of *plantaris* muscle we used the mean value of the left and right *plantaris*.

2.3. Western blot {#sec2.3}
-----------------

We used previously published protocols \[[@bib34]\] for *plantaris* homogenization, and Western blotting of the samples. Antibodies against the following proteins (with the target function) were: cytochrome C (cytC, mitochondrial hemeprotein, describes number of mitochondria), acetyl-CoA carboxylase (ACC) and its phosphorylated form pACC (enzyme involved in fatty acid biosynthesis), hypoxia inducible factor 1α (HIF1α, transcriptional regulator of cellular response to hypoxia), Pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4, regulator of glucose/fatty acid metabolism), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α, master regulator of mitochondrial biogenesis), phosphofructokinase (F6PK, a key regulatory kinase in the glycolysis), and Sirtuins 1--7. Details of the primary antibodies and methods are given in the [Supplement 1](#appsec2){ref-type="sec"}. All results were normalized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, glycolytic enzyme that catalyzes break down of glucose). In addition, the expression of mitochondrial Sirt3-5 were normalized to the markers of mitochondria: number (cytC) and activity (citrate synthase activity).

2.4. Citrate synthase activity, blood lipids, glucose, insulin and HOMA-index {#sec2.4}
-----------------------------------------------------------------------------

To determine the activity of mitochondria we measured the level of citrate synthase (CS, catalyzes the first reaction of the citric acid cycle) enzyme activity, in *plantaris* muscle as previously \[[@bib35]\]. Blood lipids were assayed from necropsy serum sample by a kinetic photometric method with KoneLab. Fasting blood samples (*in vivo*) were taken from *vena saphena*. Blood glucose was measured with glucose analyser (HemoCue Glucose 201^+^, HemoCue AB, Ängelholm, Sweden). Serum insulin was assayed with ELISA (Mercodia AB, Uppsala, Sweden). Calculation of [HO]{.ul}meostatic [M]{.ul}odel [A]{.ul}ssessment for insulin resistance (HOMA-index) is a method to assess function of pancreatic β-cells, and insulin resistance, and was calculated with an equation: (fasting blood glucose/fasting insulin \*22.4) \[[@bib36]\].

2.5. Statistics {#sec2.5}
---------------

Data were analyzed with MS-Excel 2010 and SPSS (version 22, IBM© SPSS Statictics). Results are shown as mean ± SEM. Data were assessed with Univariate Anova (UniANOVA) or two-way analysis of variance using general linear model (GLM) after verifying homogeneity of variances by the Levene's test. In case of a statistically significant interactive effect with diet and running, a full-factorial model with contrast coefficient was calculated to assign the statistical differences among the groups. If the interaction was not statistically significant, data were analyzed by the analysis of variance followed by post-hoc testing (Sidak's test or Dunnett's 2-sided t-test). The repeated observations from the same rat were accounted using linear mixed model. Type III tests of fixed effects with Sidak's adjustment for multiple comparisons were used. Pearson's correlation was calculated to estimate correlation between variables. The level of statistical significance was set at p ≤ 0.05.

3. Results {#sec3}
==========

3.1. Energy intake, body weight and body composition {#sec3.1}
----------------------------------------------------

Energy intake \[kcal/body weight\] was highest in PD groups ([Figure S2](#dfig2){ref-type="graphic"}a), being significantly higher than in water drinking controls (sedentary or running, p \< 0.001). Running increased food (p \< 0.001, [Figure S2](#dfig2){ref-type="graphic"}b) and BCAA intake (p \< 0.001, [Figure S2](#dfig2){ref-type="graphic"}c) in all protein-supplemented groups.

The intake of main nutrients differed between diet-groups ([Figure S3](#dfig3){ref-type="graphic"}), but within groups the levels remained constant throughout the intervention. Intervention did not affect continuous weight gain in any group ([Figure S2](#dfig2){ref-type="graphic"}a), but between the two body composition measurements, both the sedentary PD-group (pre vs. post intervention, p = 0.023) and RW-group (pre vs. post intervention, p = 0.001) gained weight ([Fig. 2](#fig2){ref-type="fig"}a). When combined with running, both PD and whey boosted the gain in relative lean mass (of the total body weight, p \< 0.05; ∼12 and 10.5%, respectively), while running alone had no effect ([Fig. 2](#fig2){ref-type="fig"}b). However, in all runners ([Fig. 2](#fig2){ref-type="fig"}c), the amount of fat of the total body mass decreased, the drop being largest in supplemented groups (p \< 0.05; PD+RW, −45%; W+RW -35%). Further, absolute lean mass (g) increased in all runners (p \< 0.001, data not shown).Fig. 2Changes in body composition during a 5-month intervention. (a) Weight (g) was measured with a scale, while for the (b) lean body mass (g) \[relative to body weight, BW (g)\], and (c) fat mass (g) \[relative to BW (g)\] rats were anaesthetized and measured with dual-energy X-ray absorptiometry. In the panels, \* indicates significant change within group during intervention, pre vs. post value, linear mixed model,\* p \< 0.05; \*\* 0.01 \> p ≥ 0.001; \*\*\* p \< 0.001. \# indicates significant difference as compared with ctrl-group, \# p \< 0.05, \#\# 0.001 \< p \< 0.01, \#\#\# p \< 0.001, GLM.Fig. 2

3.2. Running, aerobic capacity, and spontaneous activity {#sec3.2}
--------------------------------------------------------

The amount of voluntary running increased in all groups during the first 8--11 weeks ([Fig. 3](#fig3){ref-type="fig"}a), but to a lesser extent in the W+RW group. In the RW group, the total running distance was 740 ± 154 km (range 93--1556 km), in PD+RW 932 ± 148 km (range 380--1515 km, PD+RW vs. RW: p = 0.553) and in W+RW 495 ± 97 km (range 70--1023 km, W+RW vs. RW: p = 0.365). Although the **total** running distance in the end of intervention did not differ between the groups, the **average daily distances** were different (p \< 0.001, [Fig. 3](#fig3){ref-type="fig"}a), the PD+RW having the highest and the W+RW the lowest amount of daily running. Voluntary training improved running capacity about 8-fold in all running groups (p \< 0.001; [Fig. 3](#fig3){ref-type="fig"}b) while diet supplements had no effect.Fig. 3(a) Daily voluntary running distances \[meters (m), group average ± SEM\] were followed using the computerized recording system, the functioning of which was confirmed using uninterruptible power source. \* depicts significant difference of the PD+RW to the RW-group, p \< 0.05, ^\#^ depicts significant difference of the W+RW to the RW-group, p \< 0.05, linear mixed model. For the aerobic fitness *i.e.* running capacity we conducted treadmill exercise tests, and panel (b) shows the difference between the pre and post-values as a change in running distance (m). Effects are shown as \*\*\* p \< 0.001, linear mixed model.Fig. 3

Running in running wheels introduced a 10-fold difference in the spontaneous activity in running rats compared to the sedentary ([Fig. 4](#fig4){ref-type="fig"}a, b), the difference being especially clear during the darkness (Sed vs. RW rats, daytime: p = 0.081, and darkness: p \< 0.001). Sedentary lifestyle flattened the circadian spontaneous activity pattern ([Fig. 4](#fig4){ref-type="fig"}a, b). All rats were handled during the daytime between 14 and 17 h that introduced an insignificant induction in the activity ([Fig. 4](#fig4){ref-type="fig"}a--c).Fig. 4Continuous diurnal spontaneous activity index, shown as a mean value (±SEM, please note that error bars are slightly dissociated to diminish their overlapping) in 3 h bins, was measured during the intervention in sedentary groups (a) and in running groups (with availability to run during the activity measurement, panel b). Measurement was done for 6 animals in each group, the exception being the water drinking ctrl-group from which 4 animals were measured. In panel (c), activity of sedentary animals is shown in a larger scale. Black-and-white bars near the x-axes indicate the lighting periods in the room (lights were on between 8 a.m. and 8 p.m.). Daily handling of the rats occurred between 2--5 p.m. (rounded rectangle in line graphs a, b, c). In the panel (d), diurnal spontaneous activity (during one representative day, 24 h) is shown as divided into daytime and darkness (12 h). Number within each pie represents the group mean value of the sum of the total activity during daytime (12 h) or darkness, and the percentages show the distribution of the activity across circadian phases in each group. Differences between the groups were statistically assessed by the linear mixed model, \* p \< 0.05, difference between PD and crtl; \# p \< 0.05, difference between W and ctrl.Fig. 4

3.3. Glucose tolerance, insulin sensitivity, and fasting blood glucose {#sec3.3}
----------------------------------------------------------------------

Running improved glucose tolerance in all groups shown by the decreased AUC-values ([Table 1](#tbl1){ref-type="table"}; p = 0.001). Whey intervention brought about a ∼18% decrease in the glucose sensitivity ([Table 1](#tbl1){ref-type="table"}, glucose tolerance test, pre vs. post value: p = 0.025); whereas running had no effect; there was no difference between pre and post AUC-values (W+RW, pre vs. post: p = 0.115).Table 1AUC-indices: Area under the blood glucose curve was calculated from blood glucose values in glucose tolerance and insulin sensitivity tests (mean ± SEM), before and in the end of the intervention.Table 1GroupAUC, glucose tolerance test ^(a^AUC, insulin sensitivity test*Before interventionEnd of interventionBefore interventionEnd of intervention*ctrl1187 ± 611267 ± 107183 ± 6186 ± 5PD1164 ± 641252 ± 78**179** **± 5216 ± 5\***W**1182 ± 901397** **± 105\*174** **± 4213 ± 15\***RW1107 ± 681003 ± 51181 ± 7200 ± 6PD+RW1115 ± 76989 ± 42**176** **± 8214 ± 13\***W+RW1169 ± 581020 ± 53**172** **± 4206 ± 13\***[^2][^3][^4]

All groups became more resistant to exogenous insulin during the intervention ([Table 1](#tbl1){ref-type="table"}, [Figure S4](#dfig4){ref-type="graphic"}). At the insulin sensitivity test before intervention, blood glucose plummeted rapidly, within 10 min in all groups, while in the test after intervention, the glucose drop was significant only at 20 min after the insulin injection ([Figure S4](#dfig4){ref-type="graphic"}b). Insulin sensitivity decreased 20--22% in all sedentary and running PD- and W-groups (p \< 0.05, [Table 1](#tbl1){ref-type="table"}). Fasting blood glucose values did not differ between the groups before or after the intervention ([Figure S4](#dfig4){ref-type="graphic"}).

3.4. Serum lipids, HOMA-index, and glucose levels in the end of intervention {#sec3.4}
----------------------------------------------------------------------------

At necropsy, fasting insulin and glucose levels, and thereby HOMA-indices, were equal between the groups ([Suppl. Table 2](#appsec2){ref-type="sec"}). Diet had a general decreasing effect on serum LDL levels ([Table 2](#tbl2){ref-type="table"}; effect of PD, −33%, p = 0.062; W, −34%, p \< 0.05) although none of the treatments had a significant effect on serum total cholesterol. Neither the diets nor the running alone affected HDL level, but whey together with running increased HDL by 0.44 mmol/l (p \< 0.05, contrast to sedentary controls, [Table 2](#tbl2){ref-type="table"}). Running decreased triglycerides ([Table 2](#tbl2){ref-type="table"}; −0.18 mmol/l, −25%, p = 0.014), while PD or W did not. In comparison with the sedentary groups, running also decreased free fatty acids (−0.21 mmol/l, p = 0.007, [Suppl. Table 2](#appsec2){ref-type="sec"}). Total running amount (total distance during intervention) did not associate with blood lipids. Serum LDL was inversely associated with protein intake \[r = −0.39, p = 0.008\].Table 2Blood lipids (mean ± SEM) in the end of intervention, measured after overnight fasting from serum sample.Table 2GroupTriglycerides (mmol/l)^a^Total cholesterol (mmol/l)HDL (mmol/l)^b^LDL (mmol/l)^c,d^ctrl0.79 ± 0.123.3 ± 0.22.06 ± 0.080.93 ± 0.15PD0.70 ± 0.083.4 ± 0.2 (n = 7)2.41 ± 0.12 (n = 7)0.59 ± 0.13 (n = 7)W0.71 ± 0.102.8 ± 0.11.96 ± 0.140.55 ± 0.10RW0.64 ± 0.103.4 ± 0.22.16 ± 0.090.96 ± 0.11PD+RW**0.43 ± 0.07\***3.1 ± 0.32.19 ± 0.150.69 ± 0.15W+RW0.57 ± 0.053.5 ± 0.2***2.50 ± 0.23***^***b***^0.66 ± 0.12[^5][^6][^7][^8]

3.5. Mitochondrial markers cytC, CS activity, and PGC-1α {#sec3.5}
--------------------------------------------------------

Running increased the expression of cytC by ∼2-fold (p \< 0.001) while the diets had no effect on it ([Fig. 5](#fig5){ref-type="fig"}a). Generally, both running and diet supplement increased CS activity in *plantaris* muscle ([Suppl. Table 2](#appsec2){ref-type="sec"}, running by 1.7-fold, p \< 0.001, diets by 1.2-fold, p = 0.043). Especially whey together with running increased CS activity by 1.8 fold (p \< 0.001). Expression of PGC-1α increased by 1.8 fold in response to running ([Fig. 5](#fig5){ref-type="fig"}b; p \< 0.001).Fig. 5Protein content of (a) cytochrome C, (b) PGC-1α, (c) PDK4, (d) Acetyl-CoA-carboxylase (ACC), and (e) phosphorylated Acetyl-CoA-carboxylase (pACC) in *plantaris* muscle. Panel (f) shows the expression of phosphorylated Acetyl-CoA-carboxylase (pACC) in relation with total ACC. Representative examples of western blots are shown above each graph, gel blots are divided because the order of samples in the gel was not equal for the order of groups in results-section. Nonetheless, all gel figures originate from the samples run in the same gel. Each gel contained protein samples of all groups, and the samples run on different gels were normalized to a control sample, that was repeated in each gel. In the panels, \* indicates significant difference to sedentary control (ctrl), \* p \< 0.05; \*\* 0.01 \> p ≥ 0.001; \*\*\* p \< 0.001.Fig. 5

Markers of mitochondrial biogenesis and activity were associated with increase in running capacity: PGC-1α (r = 0.56, p \< 0.001), cytC (*i.e*. mitochondrial quantity, r = 0.44, p = 0.002), and CS (*i.e*. mitochondrial activity, r = 0.74, p \< 0.001).

3.6. Intermediary metabolic proteins {#sec3.6}
------------------------------------

Neither diets nor exercise had an effect on PDK4 ([Fig. 5](#fig5){ref-type="fig"}c) that plays a key role in regulation of glucose and fatty acid metabolism. In sedentary animals PD and W diminished ACC while in running groups both PD and W enhanced ACC \[[Fig. 5](#fig5){ref-type="fig"}d, interactive effect of running and diets (p \< 0.001)\]. Phosphorylation of ACC, that enhances fat oxidation, increased ([Fig. 5](#fig5){ref-type="fig"}e) in response to whey and to running. Thus, both diets (PD +51% and W +89%) and running without supplements (+11%) enhanced the amount of phosphorylated ACC relative to the total amount of ACC ([Fig. 5](#fig5){ref-type="fig"}f). PD increased the expression of glucose metabolism-regulating Hif1α by 4.5-fold and 3.2-fold in comparison to controls and whey (respectively) ([Fig. 6](#fig6){ref-type="fig"}a). Similarly F6PK, the rate limiting enzyme of glycolysis, was induced by PD by 3-fold and by 1.8-fold ([Fig. 6](#fig6){ref-type="fig"}b) in comparison to controls and W, respectively. Running had no effect on either Hif1α or F6PK.Fig. 6Protein content of (a) Hif1α and (b) phosphofructokinase (F6PK) in *plantaris* muscle. Representative examples of western blots are shown above each graph. Gel blots are divided because the order of samples in the gel was not equal for the order of groups in results-section. Nonetheless, all gel figures originate from the samples run in the same gel. Western blot gels were run equally as in [Fig. 5](#fig5){ref-type="fig"}. In the panels, \* indicates significant difference to sedentary control (ctrl), \* p \< 0.05; \*\* 0.01 \> p ≥ 0.001; \*\*\* p \< 0.001.Fig. 6

3.7. Sirtuins {#sec3.7}
-------------

Both diets had a similar general tendency to induce Sirt 1 (about +31%, p = 0.092, [Fig. 7](#fig7){ref-type="fig"}a), that is one of the key regulators of mitochondrial biogenesis \[[@bib12]\]. PD combined with running had most pronounced effect by enhancing Sirt1 level by 1.8-fold in comparison to controls (p = 0.034, [Fig. 7](#fig7){ref-type="fig"}a). Neither running nor protein supplements had an effect on Sirt2 ([Fig. 7](#fig7){ref-type="fig"}b). Of the effects of intervention on the other non-mitochondrial sirtuins, running decreased Sirt6, which acts as one of the key regulators of glucose homeostasis \[[@bib23]\], by 25% (p \< 0.001, [Fig. 7](#fig7){ref-type="fig"}c), and the difference was significant between all diet-matched, sedentary and RW groups (p \< 0.01 for all). However, protein drink increased Sirt6 expression in comparison to both control diet (1.5-fold, p \< 0.001) and whey (1.4-fold, p \< 0.001). Sirt6 associated with fat intake (r = 0.61, p \< 0.001), increased adiposity (r = 0.33, p = 0.023), and with the downstream targets of it: Hif1α (r = 0.60, p \< 0.001) and F6PK (r = 0.56, p \< 0.001). An inverse association was found with Sirt6 and improved running capacity (r = −0.33, p = 0.023), CS activity (r = −0.44, p = 0.002), and expression of PGC1α (r = −0.33, p = 0.022) and total ACC (r = −0.5, p \< 0.001).Fig. 7Protein content of (a) Sirt1, (b) Sirt2, (c) Sirt6, and (d) Sirt7 in *plantaris* muscle. Representative examples of western blots are shown above each graph. Gel blots are divided because the order of samples in the gel was not equal for the order of groups in results-section. Nonetheless, all gel figures originate from the samples run in the same gel. Western blot gels were run equally as in [Fig. 5](#fig5){ref-type="fig"}. In the panels, \* indicates significant difference to sedentary control (ctrl), \* p \< 0.05; \*\* 0.01 \> p ≥ 0.001; \*\*\* p \< 0.001.Fig. 7

Running and diets had an interactive effect on Sirt7 ([Fig. 7](#fig7){ref-type="fig"}d; p = 0.002). Running alone had no effect but both diets increased Sirt7 in comparison with normal diet (PD, +53%, p \< 0.001 and W, +82%, p \< 0.001, [Fig. 7](#fig7){ref-type="fig"}d). Thus, both BCAA (r = 0.68, p \< 0.001) and protein (r = 0.77, p \< 0.001) intakes were associated with Sirt7, the regulator of mitochondrial homeostasis and hepatic lipid metabolism \[[@bib24]\].

Because running induced expression of mitochondrial markers, the data of all mitochondrial sirtuins (Sirt3, 4 and 5) are shown as expression data, and as normalized to mitochondrial markers CS and cytC ([Fig. 8](#fig8){ref-type="fig"}). Sirt3 was associated with an increase in running capacity (r = 0.5, p \< 0.001), CS activity (r = 0.75, p \< 0.001), PGC1α (r = 0.71, p \< 0.001), and cytC expression (r = 0.51, p \< 0.001), Both diets (PD, +65% p = 0.001; W, +80% p \< 0001) as well as running (+114%, p \< 0.001) increased significantly Sirt3 ([Fig. 8](#fig8){ref-type="fig"}a). Despite normalization to CS the inducing effect of running and both protein supplements on Sirt3 remained significant (RW, p = 0.011; PD, p = 0.011, and W, p \< 0.001), but after normalization to cytC Sirt3 induction by running was not significant. Sirt3 was associated with increased lean mass (r = 0.57, p \< 0.001) and an inverse association was found with Sirt3 and ΔAUC in glucose tolerance tests (r = −0.34, p = 0.022). Sirt3 was also inversely associated with increased adiposity (Δfat%, r = −0.51, p \< 0.001), and serum triglyceride level (r = −0.35, p = 0.018).Fig. 8Protein content of mitochondrial Sirtuins (a) Sirt3, (c) Sirt4, and (e) Sirt5 in *plantaris* muscle. Representative examples of western blots are shown above each graph. Gel blots are divided because the order of samples in the gel was not equal for the order of groups in results-section. Nonetheless, all gel figures originate from the samples run in the same gel. Western blot gels were run equally as in [Fig. 5](#fig5){ref-type="fig"}. To account the effect of intervention on mitochondria, Sirtuins were normalized to mitochondrial markers: cytochrome C \[light grey bars in panels: (a) Sirt3, (c) Sirt4, and (e) Sirt5\] and citrate synthase activity \[(b) Sirt3, (d) Sirt4, and (f) Sirt5\]. In the panels, \* indicates significant difference to sedentary control (ctrl), \* p \< 0.05; \*\* 0.01 \> p ≥ 0.001; \*\*\* p \< 0.001.Fig. 8

Compared to sedentary controls, Sirt4 (whose the enzymatic activity is controlling BCAA catabolism \[[@bib20]\]) was enhanced by 2-fold in response to running (p \< 0.001, [Fig. 8](#fig8){ref-type="fig"}c). Independent of running, PD diminished Sirt4 expression in comparison to both control diet and whey by 1.7 fold (p \< 0.05, [Fig. 8](#fig8){ref-type="fig"}c). The diminishing effect of PD on Sirt4 remained the same after normalization to the mitochondrial markers CytC ([Fig. 8](#fig8){ref-type="fig"}c) or CS ([Fig. 8](#fig8){ref-type="fig"}d) (p = 0.003 and p = 0.002, respectively). An increase in running capacity was associated with the level of Sirt4 (r = 0.36, p = 0.015).

Both PD and W supplements (by 2.6-fold and 2.1-fold, respectively), and running (by 1.3-fold, p \< 0.001) increased Sirt5 ([Fig. 8](#fig8){ref-type="fig"}e), the regulator of energy metabolism \[[@bib21]\]. The effect remained significant even if the Sirt5 expression was normalized to the mitochondrial markers ([Fig. 8](#fig8){ref-type="fig"}e, f; p \< 0.001 for both).

4. Discussion {#sec4}
=============

Sirtuins are important regulators of energy metabolism, and by finding tools to regulate them in skeletal muscle one could mitigate MD. Because milk proteins are rich in BCAA, and their consumption improves metabolic health \[[@bib9],[@bib10]\], we hypothesized that milk protein supplements could affect Sirtuins and alleviate MD risk factors in adult, polygenic female LCR rats. LCR rats have poor running capacity based on selective breeding, but also suffer from MD risk factors \[[@bib26], [@bib27], [@bib28]\]. Because LCR rats have a genetically heterogeneous background they mimic human genetics better than inbred laboratory animals \[[@bib37]\]. Previously, it is shown that the protein levels of Sirtuins adapt to an acute or long-term stimuli like exercise or caloric restriction \[[@bib32],[@bib35],[@bib38], [@bib39], [@bib40], [@bib41]\]. Therefore we used exercise as a reference group for diet supplements. In addition that exercise induced Sirtuins 3--5 and downregulated Sirtuin 6, we found specific effects of long-term dietary supplementation with milk-based proteins on Sirtuins in skeletal muscle (*plantaris),* and on blood lipids and body composition. These findings are discussed below.

Voluntary running of the whey-supplemented group was strikingly low, especially during the first 10 weeks of the intervention, amounting to \>50% lower daily running distance compared to the other groups. It is of note, that running capacity increased, and skeletal muscle mitochondrial markers (citrate synthase, CS and cytochromeC, cytC) enhanced in a similar manner in all exercising groups despite large difference in the amount of running. Because running differed between the diet groups - especially during the first weeks of the intervention - it warrants further studies to investigate how the diets affect running motivation \[[@bib42]\]. Nevertheless, all trained LCR females improved their maximal running capacity, an indicator of aerobic fitness, in response to voluntary training. Neither of the supplemented diets had an effect on aerobic fitness. This agrees well with a human study reporting no effect on treadmill running capacity with whey supplementation \[[@bib43]\]. In contrary, a study in mice shows when combined with a different type of exercise, *i.e*., swimming, whey supplement slightly improved swimming capacity to exhaustion \[[@bib44]\].

In our study, energy intake increased as expected \[[@bib45]\], in all running groups while body weight increased only in RW and sedentary PD groups. In all running groups lean mass increased and % fat decreased while milk protein supplementation *per se* had no effects. However, when the body weight was taken into account, only the runners with supplementary diets gained in lean mass during the 5 month intervention. Also randomized clinical trials (RCTs) have shown that -- although not always - long-term exercise \[[@bib45]\] and diets enriched with milk proteins lead to favorable changes in body composition, albeit the results are depending on experimental settings and dairy protein diet availability (*ad libitum* or combined with energy restriction) \[[@bib5],[@bib46]\].

One of the risk factors in metabolic disorders is dyslipidemia, especially heightened triglyceride and lowered HDL level \[[@bib47],[@bib48]\]. However, elevated LDL cholesterol levels also associate with increased risk of atherosclerotic disease, supported by the finding that exercise reduced the risk via decreasing LDL \[[@bib48]\]. Our results show that together with voluntary running, both milk protein drink and whey protein had a similar, lowering effect on fasting blood LDL level (−32%, PD groups and −36%, W groups, in comparison to water drinking groups). Total cholesterol was unaffected by intervention treatments, but whey with running increased HDL. Only running lowered serum triglycerides and free fatty acids compared to sedentary controls. Protein intake was inversely associated with LDL level but without exercise, the diets alone did not affect blood lipids. Previously, only a few studies in obese or MD patients show similar findings of whey supplements on blood lipids, but without exercise and the follow-up times have lasted only 12 weeks or less \[[@bib47]\]. In humans, exercise with whey is shown to be effective in lowering triglycerides only \[[@bib49]\].

Glucose tolerance and insulin sensitivity were attenuated by whey and PD. However, neither of the diets affected fasting blood glucose, insulin levels, or HOMA-indices. Similar, *negative* effects on glucose tolerance and insulin sensitivity have been found previously using BCAA-rich diets but also opposite findings exist \[[@bib42]\]. Previously some RCTs and epidemiological studies have shown that dairy intake is associated with beneficial effects on lipid metabolism and MD risk factors \[[@bib50]\]. To our knowledge, there are no human studies of long-term dietary interventions, our data is the first showing the long-term effects in rat. The 5-month treatment period corresponds to ∼20% of the lifespan of female LCR rat \[[@bib29]\]; in human life it would be slightly more than 14 yrs \[[@bib51]\].

Since Sirtuins are important regulators of energy metabolism responding to metabolic demands, we wanted to determine whether the long-term supplementation of BCAA-rich milk-proteins with or without exercise would induce concurrent changes in muscle Sirtuins and their downstream targets, and improve risk factors for MD. Indeed, several coinciding changes were seen as summarized in the Graphical Abstract. Sirt2 was the only sirtuin that was not affected by exercise or supplements. The actual function of Sirt2 in skeletal muscle remains to be shown.

The combination of voluntary running and protein drink for 21 weeks caused a significant increase in Sirt1 while running alone had no effect. We also found that long-term wheel running increased the content of PGC-1α, the downstream target of Sirt1 deacetylation \[[@bib12]\]. The increase in PGC-1α seems to be independent of Sirt1 protein level, but because we did not study Sirt1 activity, the role of Sirt1 in PGC-1α function cannot be concluded. Running induced also an increase in cytC concentration with no effect of diet, suggesting that exercise activates PGC-1α-mediated mitochondrial biogenesis while milk protein does not. Another mitochondrial marker, CS activity increased not only in response to exercise, but also in response to PD and whey diets, indicating that protein supplementation has its own effect on the activity of the mitochondria. While several studies have shown that the expression of Sirt1 increases in skeletal muscle in response to acute and long-term exercise \[[@bib52],[@bib53]\], some studies found no changes or even a decrease \[[@bib54]\]. Moreover, Philp et al. showed that in mice lacking Sirt1 deacetylase activity in skeletal muscle, mitochondrial biogenesis and PGC-1α responses were not impaired during acute exercise \[[@bib55]\]. Notwithstanding, exercise is shown to increase Sirt1 activity without changes in its protein level \[[@bib53]\], and therefore Sirt1 signaling pathway needs further investigations.

Sirtuins 3, 4 and 5 are located in the mitochondria and function there as the main regulators of mitochondrial metabolic activity and flexibility \[[@bib13],[@bib20],[@bib21]\]. Sirt3 and Sirt4 were upregulated by long-term running, but also whey protein alone increased Sirt3. Combined with exercise both whey and milk protein drink, induced about 4-fold increase in Sirt3 in comparison to water drinking control and about 2-fold increase in comparison to the respective sedentary group. This upregulation remained significant even after accounting for the inductive effect of intervention on mitochondrial biogenesis. Thus, the data favors the hypothesis that exercise and milk protein supplements have additive effects, consequently enhancing mitochondrial energy metabolism. In agreement with previous studies, the running-induced upregulation of Sirt3 was associated with improved glucose tolerance and body composition. Previously, mice with muscle-specific overexpression of Sirt3 were shown to have higher energy expenditure and lower respiratory exchange ratio than wild-type animals indicating increased use of lipids for oxidative energy production \[[@bib56]\]. In these mice, Sirt3 increased the activity of AMPK that - among a plethora of other substrates -- phosphorylates ACC thus deactivates it \[[@bib56]\] turning lipid metabolism on oxidative mode. Accordingly, in our study both whey and milk protein drink alone or combined with running, increased the ratio of p-ACC and total ACC indicating enhanced oxidation of fatty acids. Unfortunately, we could not measure respiratory exchange ratios during the intervention and therefore the data of fuel use is lacking.

Running-induced increase in Sirt4 suggests increased BCAA catabolism in the trained skeletal muscle of LCR rats. However, previously Sirt4 of LCR rats was diminished after 12-week treadmill training \[[@bib35]\] and voluntary running for one year in old rats did not have any effect \[[@bib32]\] in the *gastrocnemius* muscle. Since Sirt4 is the regulator of BCAA catabolism \[[@bib20]\] further investigation is warranted to show the actual role of Sirt4 in the energy metabolism in different types of muscles, training modes and during the lifespan.

Running alone did not affect Sirt5 expression in skeletal muscle, agreeing with our previous study with old rats \[[@bib32]\]. However, milk protein and whey increased Sirt5 expression in *plantaris* muscle, independent of the normalization of the data, indicating enhanced mitochondrial energy metabolism. Thus, it suggests that specific nutrient supply, and not increased energy demand alone, is required to enhance Sirt5.

The expression patterns of both Sirt6 and Hif1α along with F6PK resembled each other in all diet groups but not in exercised ones. Exercise decreased Sirt6 expression with almost no change in Hif1α. Interestingly, our results show that casein-containing protein supplement (PD), but not whey, induced a large increase in skeletal muscle Hif1α expression, suggesting that different nutritional stimuli may regulate glycolysis via affecting the ratio of Sirt6 and Hif1α. Previously it was shown that casein-containing protein diet had a protective effect on obesity that was not seen with proteins from other sources suggesting increased futile cycling of fatty acids \[[@bib57]\]. In skeletal muscle, Sirt6 positively regulates AMPK having influence on glucose uptake, fatty acid uptake and oxidation, and mitochondrial oxidative phosphorylation \[[@bib58]\]. It is shown to act as a corepressor of Hif1α thus regulating the expression of glucose transporters and key glycolytic enzymes \[[@bib23]\]. In contrast to our findings, previous studies showed no effect on Sirt6 after 6-week treadmill running in the skeletal muscle in young healthy Wistar rats \[[@bib53]\] or after one-year running intervention in LCR rats \[[@bib32]\]. The effects of different exercise modes, diets, ageing and their combinations on the function of Sirt6 in various muscles remain to be studied.

Protein supplements increased skeletal muscle Sirt7 that was further augmented by exercise - although similarly to our previous finding \[[@bib32]\], running alone had no effect. One of the tasks of Sirt7 is to act as regulator of mitochondrial homeostasis and lipid metabolism at least in the liver \[[@bib24]\]. However, the effects of Sirt7 on skeletal muscle metabolism are poorly known, and further research is needed.

5. Conclusions {#sec5}
==============

Collectively, our data support the idea that combined, long-term exercise and dietary milk proteins, especially whey, are beneficial for blood lipid profile and body composition. Running increased energy intake and lean mass without affecting body weight. The data adds to existing knowledge by showing the effects of long-term milk protein consumption or whey at cellular level, enabling us to screen the underlying health-beneficial mechanisms in the skeletal muscle. The metabolic effects of long-term running and/or milk protein consumption may be - at least partially - regulated by Sirtuins responding in concert to metabolic challenges. Notably, milk protein supplements had some favorable effects on metabolism, even without running.
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[^1]: Present address: Firstbeat Technologies Oy, Jyväskylä, Yliopistonkatu 28A, FI-40100 Jyväskylä, Finland'.

[^2]: Number of animals in each group is 8, except in PD+RW n = 7.

[^3]: ^a^ Significant effect of running, p = 0.001 (GLM).

[^4]: \* Significant effect of intervention, difference between pre and post -value, p \< 0.05 (GLM).

[^5]: ^a^ Significant effect of running, p \< 0.05.

[^6]: ^**b**^ Interactive effect of running and protein supplements, p \< 0.05; ***contrast*** of W+RW to ctrl p \< 0.05).

[^7]: ^c^ Significant effect of whey, p \< 0.05.

[^8]: ^d^ Main effect of diet, p \< 0.05.
